Guardian Wealth Advisors (North Carolina)’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-787
Closed -$342K 553
2025
Q1
$342K Buy
787
+64
+9% +$25.7K 0.03% 230
2024
Q4
$267K Buy
723
+52
+8% +$21.8K 0.02% 264
2024
Q3
$349K Sell
671
-20
-3% -$10.7K 0.04% 199
2024
Q2
$374K Sell
691
-9
-1% -$4.76K 0.04% 181
2024
Q1
$363K Buy
700
+60
+9% +$29.8K 0.04% 191
2023
Q4
$302K Buy
640
+31
+5% +$14.3K 0.05% 193
2023
Q3
$265K Sell
609
-18
-3% -$8.16K 0.05% 195
2023
Q2
$279K Buy
627
+155
+33% +$71.5K 0.05% 177
2023
Q1
$217K Buy
+472
New +$225K 0.04% 205

Other funds holding ELV

Guardian Wealth Advisors (North Carolina)'s ELV Position: Q2 2025 in Review

Guardian Wealth Advisors (North Carolina) sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 787 shares — an estimated $342K sold.

Guardian Wealth Advisors (North Carolina) first reported a position in ELV in Q1 2023 and held it in 9 quarters. The position peaked at $374K in Q2 2024. 1,590 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Guardian Wealth Advisors (North Carolina) reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Guardian Wealth Advisors (North Carolina) sold 787 Elevance Health shares in Q2 2025, an estimated $342K.
  • Guardian Wealth Advisors (North Carolina) first reported a position in Elevance Health in Q1 2023 and held it in 9 quarters.
  • Guardian Wealth Advisors (North Carolina)'s Elevance Health position peaked at $374K in Q2 2024.
  • 1,590 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Guardian Wealth Advisors (North Carolina)'s 13F filing for Q2 2025, filed 14 Aug 2025.